Steph & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33K Buy
382
+36
+10% +$3.17K 0.01% 203
2026
Q2
$27.1K Sell
346
-269
-44% -$21.7K 0.01% 211
2026
Q1
$53.3K Buy
615
+213
+53% +$20.4K 0.02% 191
2025
Q4
$38.6K Buy
402
+306
+319% +$29.7K 0.01% 214
2025
Q3
$9.14K Buy
+96
New +$8.82K ﹤0.01% 297
2025
Q1
– Sell
-1,065
Closed -$85.1K – 275
2024
Q4
$85.1K Buy
1,065
+1,007
+1,736% +$87.2K 0.03% 159
2024
Q3
$5.22K Buy
+58
New +$4.88K ﹤0.01% 284
2023
Q4
– Sell
-133
Closed -$10.4K – 278
2023
Q3
$10.4K Buy
+133
New +$11.1K 0.01% 245
2020
Q2
– Sell
-100
Closed -$9K – 256
2020
Q1
$9K Hold
100
– – 0.01% 215
2019
Q4
$11K Buy
+100
New +$11K 0.01% 225

Other funds holding MDT

Steph & Co's MDT Position: Q3 2026 in Review

Steph & Co increased its Medtronic (MDT) stake by 10% in Q3 2026, buying an estimated $3.17K and bringing the position to 382 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #203.

Steph & Co first reported a position in MDT in Q4 2019 and has held it in 10 quarters since. The position peaked at $85.1K in Q4 2024. 403 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Steph & Co held 382 shares of Medtronic worth $33K as of Q3 2026.
  • Steph & Co bought 36 Medtronic shares in Q3 2026, an estimated $3.17K.
  • Medtronic made up 0.01% of Steph & Co's portfolio in Q3 2026, its #203 holding.
  • Steph & Co first reported a position in Medtronic in Q4 2019 and has held it in 10 quarters since.
  • Steph & Co's Medtronic position peaked at $85.1K in Q4 2024.
  • 403 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Steph & Co's 13F filing for Q3 2026, filed 7 Oct 2026.